Results 151 to 160 of about 12,730,863 (301)

Optimising Asparaginase Use and Managing Hypersensitivity in Australasia—A Clinical Practice Guideline From the Australian and New Zealand Children's Haematology/Oncology Group

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background Asparaginase is a critical component of modern multi‐agent chemotherapy regimens for paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma, with inadequate exposure leading to inferior patient outcomes. Objectives To develop a clinical practice guideline for the use of asparaginase products in the Australasian context.
Matthew J. O'Connor, Michelle Martin, Sarah M. Trinder, Draga Barbaric, Diane Hanna, Chow Y. Lai, Michael P. Osborn, Tim Prestige, Bryony Ross, Leanne Super, Thomas Walwyn, Stacie S. Wang, Andrew Wood, Andrew S. Moore, Rishi S. Kotecha, Siobhan Cross   +15 more
wiley   +1 more source

Case Report: Immunophenotypically diverse immature patterns, including variable TdT expression, in aggressive B-cell lymphomas and leukemia with MYC rearrangement

Frontiers in Oncology
This study is a retrospective analysis of our case series and literature review of aggressive B-cell lymphomas with MYC rearrangements that show immunophenotypic immaturity, including expression of terminal deoxynucleotidyl transferase (TdT), weak or ...
Daishi Kato, Daishi Kato, Takahiro Fujino, Reiko Isa, Haruya Okamoto, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Hitoji Uchiyama, Masafumi Taniwaki, Aya Miyagawa-Hayashino, Junya Kuroda   +12 more
doaj   +1 more source

Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.

Journal of Clinical Oncology, 2016
S. Leprêtre, A. Touzart, T. Vermeulin, J. Picquenot, A. Tanguy‐Schmidt, G. Salles, T. Lamy, M. Béné, E. Raffoux, F. Huguet, P. Chevallier, S. Bologna, R. Bouabdallah, J. Benichou, J. Briére, A. Moreau, Valérie Tallon-Simon, Stéphanie Seris, C. Graux, V. Asnafi, N. Ifrah, E. Macintyre, H. Dombret   +22 more
semanticscholar   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

Transplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez, Carla Niveyro, Pedro Andrés Villalba Apestegui, Victoria Isabel Martin, Lucila María Compañy Kec, María Cynthia Tomasino, Mariana del Carmen del Marull, Haydee Ingrid Bernard, Claudia Patricia Lorena Fernández, Flavia Marcela Pelech, Maria Fernanda Tosin, María Fernanda González‐Hobecker, Karen Beatrice Duranona, Angela Daiana Jara, Justus Cornely, Oliver A. Cornely, Jon Salmanton‐García   +16 more
wiley   +1 more source

Implantação da análise do conteúdo de DNA por citometria de fluxo para avaliação do prognóstico de hemopatias malignas nos pacientes atendidos pelo serviço de hematologia do Hospital Universitário da Universidade Federal de Santa Catarina [PDF]

, 2014
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-graduação Multidisciplinar em Saúde, Florianópolis, 2014Os cânceres são doenças que apresentam expansão clonal descontrolada de células ...
Mengatto, Vanessa
core  

The role of local radiation therapy for mediastinal disease in adults with T‐cell lymphoblastic lymphoma

Cancer, 2002
B. Dabaja, Chul S. Ha, D. Thomas, Richard B. Wilder, R. Gopal, J. Cortes, C. Bueso-Ramos, M. Hess, James D. Cox, H. Kantarjian   +9 more
semanticscholar   +1 more source

Splenic B Lymphoblastic Lymphoma [PDF]

, 2020
openaire   +1 more source

Reactogenicity and Immunogenicity of RSV Vaccines in Immunocompromised Individuals With Hematological Malignancies

Transplant Infectious Disease, EarlyView.
In adults with hematologic malignancies, RSV vaccination was safe and induced antibody and T‐cell responses. However, antibody levels were lower and declined more rapidly than in healthy controls. While early immune responses were evident, reduced magnitude and durability of protection suggest the need for optimized vaccination strategies in this high ...
Alisse Hannaford, Zoe Swank, Simon D. van Haren, Natalie Izaguirre, Caitlin Syphurs, Zhou Lan, Bridget Yates, Urwah Kanwal, Grace Valentine, Ella Woehl, David Regan, Hannah Levine, Alexandra Tong, Maria Shehata, Fathia Oladipupo, Colleen Sedney, Kevin Ryff, Sanya Thomas, Joann Diray‐Arce, Xiaofang Li, Kimberly A. Dufresne, Lindsey A. Parisi, Aidan Eustace, Louise Hansen, David R. Walt, Ofer Levy, Amar Kelkar, Robert J. Soiffer, Vincent T. Ho, Lindsey R. Baden, Nicolas C. Issa, Ann E. Woolley, Amy C. Sherman   +32 more
wiley   +1 more source

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland

Annals of Hematology
Lymphoblastic lymphoma (LBL) is a rare, aggressive malignancy comprising T-cell (T-LBL) and B-cell (B-LBL) subtypes. While outcomes for LBL have improved, comprehensive national data on clinical and biological features remain limited.
Amélie Trinquand, David R. Betts, Sean Rooney, Lorna Storey, Peter McCarthy, Neil Barrett, Jonathan Bond, Aengus O’Marcaigh, Andrea Malone, Owen P. Smith   +9 more
doaj   +1 more source

Recurrent B Lymphoblastic Lymphoma [PDF]

, 2020
openaire   +1 more source